Bhabatosh Das

Max Healthcare

Papers

1

Total Citations

10

H-Index

1

About

Bhabatosh Das is a leading figure in urologic oncology, with a focused expertise in nephron-sparing surgery for complex renal tumors. His major contributions center on advancing surgical outcomes for patients with highly challenging kidney cancers, particularly those with RENAL nephrometry scores of 10 or higher. In his pivotal 2022 study, Das conducted a rigorous propensity score-matched cohort analysis comparing laparoscopic partial nephrectomy (LPN) and robotic partial nephrectomy (RPN). This work, which has garnered 10 citations, systematically evaluated "trifecta" and "pentafecta" outcomes—composite metrics that assess cancer control, renal function preservation, and complication rates. By demonstrating the comparative effectiveness of these minimally invasive approaches, Das has provided critical evidence to guide surgical decision-making for high-complexity tumors. His research directly impacts clinical practice, helping surgeons optimize techniques to improve patient recovery and long-term renal health. Das’s work stands as a valuable resource for trainees and specialists alike, bridging the gap between surgical innovation and real-world patient outcomes in the evolving landscape of robotic and laparoscopic urology.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Trifecta and Pentafecta Outcomes in Laparoscopic and Robotic Nephron-Sparing Surgery for Highly Complex Renal Tumors: A Propensity Score-Matched Cohort Analysis
10 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Max Healthcare

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago